iBio, Inc. — Director's Dealing 2013

Mar 4, 2013

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: iBio, Inc. (IBIO)
CIK: 0001420720
Period of Report: 2013-02-21

Reporting Person: Kain Scott (Chief Financial Officer)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$.66	2023-02-18	Common Stock (100000)		Direct

Footnotes

F1: The option vests in three equal annual installments beginning on the first anniversary of the date of grant.